Tuesday, April 21, 2026Global tech, startups & capital — covered for Africans.
Yemaachi Biotechnology uses AI, genomics, and immunology for cancer diagnostics tailored to African genetic profiles.
Auto-discovered — editorial review pending
Yemaachi Biotechnology, a Ghanaian startup, is using AI to analyze genomic and clinical data to improve cancer detection accuracy and create a bio-cancer database relevant to African populations. Existing diagnostic models use non-African genetic data, leading to inaccuracies when applied in Africa. Yemaachi’s solution helps clinicians make more informed treatment decisions by enabling them to capture more accurate data corresponding with a database of African genomic information.
